Register entry
Hefei Donghetai Pharmaceutical Technology Co Ltd
Data as of · How to read this entry
- Registered sites
- 1
- Active NDC listings
- 0
- Live patents
- 0
- Countries
- 1
- Base
- China
Authorisation
Registered operations
Analytical testing1Active ingredient (API) manufacture1Labelling1Packaging1Relabelling1Repackaging1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Hefei Donghetai Pharmaceutical Technology Co., LtdRegistrant: Hefei Donghetai Pharmaceutical Technology Co Ltd | B204, Zhongke Zicheng Incubation Base, No. 23 Hangbu Road, Xingyuan Community Service Center, High tech Zone, Hefei, Anhui 230088, China (CHN) | Analytical testing, Active ingredient (API) manufacture, Labelling, Packaging, Relabelling, Repackaging | 3037641394510698839 |
Neighbours
Registered in the same town
4Compare
Comparable companies in China
- Qingdao Biopeptek Co Ltd1 site · 110 NDC
- Shenzhen iShan Technology Co Ltd1 site · 84 NDC
- Xiamen Kang Zhongyuan Biotechnology Co., Ltd.1 site · 68 NDC
- Jianerkang Medical Co Ltd1 site · 56 NDC
- Zhejiang Ausun Pharmaceutical Co., Ltd.1 site · 55 NDC
- Guangdong Aimu Biological Technology Co Ltd1 site · 39 NDC
- Shenzhen Xinxin Yunhai Technology Co., Ltd.1 site · 37 NDC
- Guangzhou Haishi Biological Technology Co., Ltd.1 site · 34 NDC
- Guangzhou Borderless Technology Co., Ltd.1 site · 33 NDC
- Hubei Gedian Humanwell Pharmaceutical Co., Ltd1 site · 31 NDC
Enquiry
Common questions
- Is Hefei Donghetai Pharmaceutical Technology Co Ltd FDA approved?
- Hefei Donghetai Pharmaceutical Technology Co Ltd holds 1 FDA-registered establishment in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Hefei Donghetai Pharmaceutical Technology Co Ltd's drugs manufactured?
- The FDA register lists Hefei. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, packaging, relabelling, repackaging.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.